Company Overview Graphics.png

Company Overview

Creso was created to bring pharmaceutical expertise and methodological rigour to the world of cannabis and deliver quality products to people and animals everywhere. Founded by a team of highly-experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.

As a global operation since inception, Creso’s experienced leadership and geographical agility has enabled tactical expansion in a diverse range of markets:

  • First to import medicinal cannabis into Australia

  • First launches of innovative products into Switzerland for humans and animals

    • Launch of anibidiol®: the first hemp CBD based complementary feed in animal health in partnership with Virbac Switzerland (Global Animal Health company)

    • Launch of cannaQIX®: the first CBD nutraceutical in human health in partnership with Doetsch Grether AG Switzerland (Swiss OTC Pharma)

  • Formally entered the Canadian market by acquiring Mernova, a Nova Scotia based Medical Cannabis growing operation

  • Pioneered new opportunities for cannabis and hemp derived ingredients in the lifestyle space, specifically chocolates and alcoholic and non-alcoholic beverages

Company Overview Graphic.png